Alcohol and Caffeine as Triggers of Arrhythmias (or not?)

Michael Zhang, MD, PhD is an Assistant Professor in the Cardiovascular Division, Department of Medicine at the University of Minnesota Medical School, USA. His research focuses on the mechanisms linking atrial myopathy and atrial fibrillation, using an integrated approach that spans epidemiology, advanced cardiac imaging, translational animal models, and molecular signaling. He has authored numerous peer-reviewed publications in journals such as Circulation, JAMA, JACC, and PNAS, and is the recipient of multiple NIH and American Heart Association research awards.

Gregory Marcus is a Professor of Medicine at the University of California, San Francisco, and serves as Associate Chief of Cardiology for Research at UCSF Health. He is also the inaugural Endowed Professor of Atrial Fibrillation Research and an Associate Editor of JAMA (Journal of the American Medical Association). Prof. Marcus is an internationally recognized cardiologist and clinical scientist whose research focuses on atrial fibrillation, cardiac electrophysiology, and digital health. His work integrates large-scale mobile health technologies, wearable sensors, and digital platforms to investigate the mechanisms, prevention, and management of cardiac arrhythmias, as well as the cardiovascular effects of modifiable lifestyle factors, including alcohol, caffeine, and tobacco use. Prof. Marcus has published extensively in leading journals, including The New England Journal of Medicine, JAMA, Circulation, et al, making significant contributions to advancing precision prevention and digital health approaches in cardiovascular disease.

Iokfai Cheang is an Associate Professor and Attending Cardiologist in the Department of Cardiology at the First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital). His research interests include heart failure, cardiomyopathy, and coronary artery disease. He has published more than 40 papers as a first or co-first author in journals including Nature Medicine, European Journal of Heart Failure, BMC Medicine, and JAHA, with over 100 additional publications as a co-author. He is a recipient of the First-Class Science and Technology Award from the Chinese Association of Integrative Medicine and has participated in multiple national-level research projects. He currently serves on several academic committees and as a Youth Editorial Board Member of The Journal of Cardiovascular Aging (JCA) and Cardiovascular Innovations and Applications (CVIA).

Dr. Zhixing Fan, a Physician from The First College of Clinical Medical Sciences in China Three Gorges University. He primarily focuses on the clinical diagnosis and treatment of cardiovascular diseases, with particular expertise in interventional cardiology. His research interests center on cardiovascular aging and metabolic disorders, exploring the molecular mechanisms underlying the development and progression of heart and vascular diseases. Dr. Fan has led several national and provincial-level research projects and has published multiple papers in peer-reviewed international journals. He has received recognition for his outstanding contributions to clinical practice and scientific research, earning several provincial science and technology awards.